TCT 419: Pulse Intravascular Lithotripsy to Open Vessels with Calcific Walls and Enhance Vascular Compliance and Remodeling: First-in-Human Cases from the POWER-PAD 1 Study

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Abiomed; Boston Scientific Corporation; Cordis Corporation, a Johnson & Johnson company; Medtronic; Siemens Healthineers